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Summary
Nuclear receptors are a family of transcription factors
with structurally conserved ligand binding domains
that regulate their activity. Despite intensive efforts to
identify ligands, most nuclear receptors are still “or-
phans.” Here, we demonstrate that the ligand binding
pocket of the Drosophila nuclear receptor E75 contains
a heme prosthetic group. E75 absorption spectra, resis-
tance to denaturants, and effects of site-directed mu-
tagenesis indicate a single, coordinately bound heme
molecule. A correlation between the levels of E75
expression and the levels of available heme suggest
a possible role as a heme sensor. The oxidation state
of the heme iron also determines whether E75 can
interact with its heterodimer partner DHR3, suggest-
ing an additional role as a redox sensor. Further, the
E75-DHR3 interaction is also regulated by the binding
of NO or CO to the heme center, suggesting that E75
may also function as a diatomic gas sensor. Possible
mechanisms and roles for these interactions are dis-
cussed.
Introduction
Nuclear receptors belong to a superfamily of transcrip-
tion factors that share a common domain architecture,
including a highly conserved DNA binding domain
(DBD) and a structurally conserved ligand binding do-
main (LBD). The LBD acts as a molecular switch, under-
going conformational changes upon ligand binding that
cast off associated chaperone and co-repressor pro-
teins. These changes, in turn, affect subcellular local-
ization, dimerization, DNA binding, coactivator binding,
and/or transcriptional activity (reviewed by Glass and
Rosenfeld, 2000). All known nuclear receptor ligands
are able to move readily between and within cells, mak-*Correspondence: h.krause@utoronto.caing them ideal inter- and intracellular messengers or
hormones.
Three classes of nuclear receptors have been defined
based on the type of ligand that they bind (Chawla et
al., 2001; Moreau et al., 1988). The endocrine receptors
bind ligands such as steroid hormones and fat-soluble
vitamins with high affinity. Lipid receptors typically bind
dietary, bioactive, or exogenous lipids with lower affin-
ity. Finally, nuclear receptors with no known ligands are
classified as orphan receptors. The identification of li-
gands for nuclear receptors, particularly for the latter
class of orphan receptors, has received a great deal of
attention, in large part because nuclear receptors play
major roles in development, metabolism, reproduction,
and disease and because the nature of their ligands
makes them excellent targets for pharmaceutical inter-
vention.
Of the 18 classical nuclear receptors found in Dro-
sophila, only one, the ecdysone receptor (EcR), has a
known ligand. When heterodimerized with Ultraspiracle
(USP), which is the Drosophila homolog of Retinoid-X
receptor (RXR), EcR can respond to ecdysteroid
pulses, activating a cascade of nuclear receptor gene
interactions (reviewed in Thummel, 1995). One of these
EcR/USP target genes, Eip75B, encodes the nuclear re-
ceptor E75 (Segraves and Hogness, 1990). As an early
ecdysone-responsive gene product, E75 is thought to
regulate a subset of the developmental processes initi-
ated by ecdysone signals. E75 also appears to function
upstream of the ecdysone-mediated nuclear receptor
cascade, as it is required for ecdysone synthesis (Bia-
lecki et al., 2002). Germline clones of E75 null mutants
arrest during mid-oogenesis (Buszczak et al., 1999),
while zygotic mutations are embryonic lethal, with gut
and metamorphosis defects. Although not exhaustively
researched, later roles include eye and limb develop-
ment (D’Avino and Thummel, 1998) and the coordina-
tion of juvenile hormone and ecdysone signals during
larval molts and metamorphosis (Dubrovskaya et al.,
2004). Insect orthologs of Drosophila E75 are also
actively expressed during larval development, pupar-
iation, and oogenesis (Jindra et al., 1994; Palli et al.,
1997, 1995; Siaussat et al., 2004; Swevers et al., 2002a;
Zhang et al., 2004). A putative ortholog of E75 has been
identified outside the insect world in the shrimp Meta-
penaus ensis, where it is also expressed during molting
(Chan, 1998). In vertebrates, the closest homologs are
members of the orphan Rev-Erb family.
The Eip75B gene produces three splice variants,
E75A, B, and C, each with a different N-terminal region
(Segraves and Hogness, 1990). E75B is unique in that
it lacks one of two zinc fingers, both of which are re-
quired for DNA binding. Despite their differences, the
three protein variants appear to have significant func-
tional redundancy (Bialecki et al., 2002). While zygotic
knockout of all three isoforms is embryonic lethal, iso-
form-specific mutants survive until much later. All three
isoforms, including E75 isoforms from other insects,
interact with a second nuclear receptor, HR3 (Hiruma
and Riddiford, 2004; Swevers et al., 2002b; White et al.,
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1961997). These interactions interfere with the ability of
hHR3 to activate target genes.
Here, we present evidence that the molecule bound i
2within the ligand binding pocket of E75 is protoporphy-
rin IX coordinated to iron, commonly known as heme. t
oThe iron center of E75-heme can be reversibly oxidized
and reduced, which affects the ability of E75 to bind the t
Ddiatomic gas messengers nitric oxide (NO) and carbon
monoxide (CO). NO, CO, and redox state also affect the c
binteraction between E75 and its heterodimer partner
DHR3. These findings suggest a number of possible c
developmental and physiological functions known to
be regulated by heme, NO, and CO. Although heme and u
pgas binding transcription factors have previously been
identified (Aono et al., 1996; Dioum et al., 2002; Ogawa m
3et al., 2001; Shelver et al., 1997), the binding of these
molecules to a nuclear receptor is unprecedented. 6
m
aResults
g
pDoes E75 Contain a Ligand?
iNuclear receptor proteins produced in heterologous
mcell systems often copurify with small molecules that, in
omany cases, help to stabilize the protein and to provide
binsights into the properties of the true ligand (Billas et
aal., 2001; Dhe-Paganon et al., 2002; Potier et al., 2003;
Stehlin et al., 2001; Wisely et al., 2002). Upon expres-
Dsion of the E75 ligand binding domain (E75 LBD) in
ME. coli and subsequent purification, the purified protein
apossesses a deep red color (Figure 1A), suggesting that
sit copurifies with a small molecule chromophore.
tA commonly bound molecule in proteins that display
ba red color is heme. Heme-containing proteins display
bcharacteristic electronic absorption spectra that in-
oclude a major peak, typically at 400–450 nm (the γ or
u“Soret” peak), and two minor peaks (β and α peaks) in
hthe range of 500–650 nm. The spectrum of aerobically
tisolated E75 also produces the characteristic peaks of
aheme-containing proteins (Figure 1B): specifically, an α
speak at 575 nm, a β peak at 544 nm, and a γ peak at
a425 nm. The positions of the peaks suggest that the
(heme iron is oxidized (Fe(III) form), as might be ex-
ppected given that E75 was purified under aerobic con-
bditions. Consistent with this assumption, the addition
(of oxidizing agents has no affect on the spectrum of
sthe aerobically purified protein (data not shown). In
tcontrast, addition of the reducing agent dithionite shifts
tthe α, β, and γ absorbance peaks to 559, 531, and 426
inm, respectively, consistent with conversion of the
theme iron to the ferrous form (Fe(II)).
tTo see if the heme group of E75 can be reversibly
coxidized and reduced, the reduced form was treated
with the oxidizing agent ferricyanide. Ferricyanide ab-
sorbs very strongly below 500 nm, masking any effects I
Ion the E75 γ absorption peak. However, reversion of the
α and β peaks to that seen in the Fe(III) form is clear a
s(data not shown).
We also expressed the E75 LBD and full-length pro- w
wtein in SF9 cells, S2 cells, and developing flies. In all
cases, the affinity-purified proteins are red and show i
8the same absorption spectra as shown in Figure 1B.
Figure 1C shows the absorption spectrum of a multiply e
stagged E75 LBD protein affinity purified from pupae.To provide stronger evidence for the presence of
eme, purified E75 LBD was subjected to nondenatur-
ng electro-spray mass spectrometry (ES-MS) (Loo,
000). The multiply charged protein ions observed in
he mass spectrum (Figure 2A) correspond to a mass
f 30817.4 Daltons (Da), which is 616.3 Da heavier than
he predicted mass of the E75 LBD protein (30201.1
a). A significant peak at 616.2 m/z is also observed,
onsistent with partial removal of the ligand by the ion
eam. These masses correspond well with the theoreti-
al mass of heme (616.48 Da).
Subsequent collision-induced dissociation (CID) was
sed to remove the ligand of the protein-ligand com-
lex peak at 2802.39 m/z seen in Figure 2A. New
asses corresponding to unliganded E75 LBD, at m/z
020.96 (10+) and m/z 2746.27 (11+), and to heme at
16.19 Da were produced (Figure 2B). A small peak at
/z 557, also seen in the CID spectrum, corresponds to
characteristic ion arising from the loss of a CH2COOH
roup from heme. E75 LBD purified from insect cells
roduces the same sets of peaks (data not shown). We
nfer from these results that the dissociated heme
olecule is tightly bound to the E75 LBD at a stoichi-
metry of 1:1. This stoichiometry was further verified
y comparing the molar ratios of protein (amino acid
nalysis) and iron (atomic absorption) (data not shown).
oes Heme Function as an E75 Ligand?
ost nuclear receptors can be found in both the apo
nd ligand bound forms. However, under our expres-
ion and purification conditions, no apo-E75 was de-
ected. To test whether the heme moiety in E75 can
e dissociated, His-tagged E75 was bound to nickel
eads and then treated with increasing concentrations
f the denaturant guanidine hydrochloride (GdnHCl). El-
ates were collected and monitored for heme or E75-
eme by electronic absorption (Figure 3A). The eluates,
reated with up to 5M GdnHCl, contained no significant
mount of heme, protein bound or free. Extensive dialy-
is of the protein-heme complex against 100 mM EDTA
lso failed to dissociate or chelate the heme bound iron
data not shown). Dissociation of the heme-E75 com-
lex also failed to occur when the protein was incu-
ated in the presence of cellular or embryonic extracts
data not shown). These results, taken together with the
tability of the E75-heme complex during mass spec-
rometry, are consistent with the heme moiety being
ightly bound and well protected within the ligand bind-
ng pocket of the LBD. Furthermore, our inability to de-
ect apo-E75 in any of the tested cell types suggests
hat heme may be essential for protein folding and ac-
umulation.
s E75 a Heme Sensor?
f E75 protein is dependent on heme for stability and
ccumulation, then varying the levels of cellular heme
hould alter the expression levels of E75 protein. This
as tested by supplementing SF9 insect cell media
ith heme. Figure 3B shows that supplemental heme
ncreased the amount of E75 LBD expressed by about
-fold (1.57 mg −heme versus 11.6 mg +heme). Similar
ffects were seen with full-length E75A (data not
hown). The addition of heme to SF9 cells infected with
E75 is a Heme-Containing Nuclear Receptor
197Figure 1. The E75 LBD Copurifies with a
Chromophore
(A) Photo of HIS-tagged E75 LBD following
expression in E. coli and binding to a Ni-NTA
column.
(B) Electronic absorption spectra of E75 LBD
purified aerobically from E. coli (black trace)
and after reduction (gray trace).
(C) Electronic absorption spectrum of E75
LBD affinity purified from flies. The inset shows
a silver-stained gel of the purified protein.viruses expressing other nuclear receptor LBDs had no
effect on their expression levels (data not shown). We
conclude that heme is specifically required for E75 LBD
stability, and that levels of E75 expression are propor-
tional to the levels of available heme. Thus, E75 could
function as a heme sensor, accumulating and regulat-
ing gene expression in accordance with the levels of
available heme.
How Is Heme Bound?
The majority of known heme-protein interactions are
mediated by coordinate bonds between the heme cen-
ter and histidine side chains. E75 has four well-con-
served His residues in the LBD (Figure 4A). To test if
these might be important for heme binding, each resi-
due was mutated to Ala and Phe, residues that are
structurally similar to His but do not have the abilityto form coordinate bonds. The mutant proteins were
expressed in bacteria, purified, and examined for color
and absorption. Figure 4B shows spectra of each mu-
tant following identical purifications with a single affin-
ity column. Mutation H585F has no affect on E75 ex-
pression or heme binding and, although H416F and
H585A result in a substantial reduction of soluble pro-
tein recovered, both exhibit characteristic heme ab-
sorption peaks. Conversely, His364F/A and His574F/A
result in no obvious protein band or heme absorption
peak. Since the H416 and H585 mutants still retain the
ability to bind heme, they are poor candidates for resi-
dues that bind directly to the heme iron. H364 and
H574, however, are good candidates, although the ef-
fects observed could also be due to disrupted protein
folding. Interestingly, these two critical residues are the
most highly conserved in E75 orthologs and homologs,
Cell
198Figure 2. ES-MS Spectrum of the E75 LBD-
Ligand Complex
(A) ES-MS under nondenaturing conditions.
Deconvolution of the differentially charged
peaks (10+– 12+) in the higher m/z range re-
veal a protein-heme complex.
(B) Q-TOF CID Spectrum of the E75 LBD-ligand
complex ion (11+) at 2802.39 m/z (from [A]
above).ranging as far away evolutionarily as the mammalian r
dRev-Erb proteins (Figure 4A).
L
(Is E75-Heme a Redox Sensor?
(To identify possible cofactors for further studies on the
crole of heme in E75, we designed and obtained pep-
(tides corresponding to 40 putative interaction binding
motifs. The peptides were then tested in a high-through-
sput “Stargazer” screen (see Experimental Procedures).
aTypically, proteins in this screen show increased sta-
gbility in the presence of ligand, which results in an in-
Kcrease in their denaturation transition temperature.
(Nonspecific interactions either have no effect or desta-
ibilize the target protein, the latter resulting in a de-
crease in the transition temperature. Figure 5A shows tesults for the 30 of 40 peptides that generated usable
ata. Binding of the FTZ-F1 LBD interacting with the
XXLL motif of its Fushi tarazu protein cofactor
Schwartz et al., 2001) is shown as a positive control
Figures 5A and 5B). Addition of the FTZ peptide in-
reases FTZ-F1 thermostability by approximately 4°C
Figure 5B).
Of the 30 peptides tested, one produces statistically
ignificant increases in the E75 LBD transition temper-
ture. This peptide, which corresponds to the AF2 re-
ion of the E75 heterodimer partner DHR3 (NVVFPALY
ELFSIDSQQD), increases E75 thermostability by 2.9°C
Figure 5C). This result suggests that the E75-DHR3
nteraction may be mediated, in part, by contacts be-
ween the DHR3 AF2 motif and the E75 LBD. Interest-
E75 is a Heme-Containing Nuclear Receptor
199Figure 3. Stability of E75-Heme Interaction
(A) Absorbance readings are shown for Ni++ purified His-tagged E75 treated with increasing concentrations of GdnHCl at 395 nm (solid line)
and 425 nm (dashed line). Buf F represent the low pH elution.
(B) Expression and purification of E75 LBD from SF9 cells without additives to the growth media. The upper panel shows a Coomassie-
stained gel of the purified fractions. The lower panel shows photos of the tubes containing the corresponding fractions loaded on the
gel above.
(C) Expression and purification of E75 in the presence of 1.5 mM supplemental hemin.ingly, this thermostabilization only occurrs when bind-
ing is carried out with the reduced Fe(II) form of E75
(Figure 5D). As with the previous absorption spectra
data, this result is consistent with the possibility that
E75 is a cellular redox sensor.
Is E75-Heme a Gas Sensor?
For many heme-containing proteins, the heme moiety
facilitates the binding of diatomic gases (for review see
Gilles-Gonzalez and Gonzalez, 2005). In these studies,
interactions were demonstrated using diagnostic changes
in protein electronic absorption peaks in the presence
of O2, NO, or CO.
Addition of O2 to Fe(II) E75 has no immediate effect
on the spectrum. Only after several hours does the
spectrum shift gradually to that of the oxidized form
(data not shown), suggesting that E75-heme does not
act as a direct O2 sensor. On the other hand, addition
of either CO or NO to Fe(II) E75 causes immediate and
substantial shifts in the spectra (Figure 6A). CO coordi-
nation causes a narrowing and blue shift of the Soret
peak (421 nm) as well as broadening of the α/β region.
Addition of NO results in a significant broadening
and blue shift of the Soret peak (391 nm) and completeloss of peak resolution in the α/β region. Although NO
also acts as an oxidizing agent, the rapid shift of the
spectrum and the presence of a large excess of reduc-
ing agent suggests that this spectrum represents NO
coordinately bound to Fe(II) E75. These spectra are
highly similar to those of other heme-containing gas
sensors such as CooA and sGC (Aono et al., 1996;
Reynolds et al., 2000; Shelver et al., 1997; Stone and
Marletta, 1994).
The interaction of CO with Fe(II) E75 was also tested
using Stargazer (Figure 6B). The short half-life of NO in
solution prevented its use in this assay (Stargazer takes
1–2 hr). CO, which is relatively stable in solution, in-
creased the Fe(II) E75 transition temperature by 6.4°C.
No effect of CO was observed on oxidized Fe(III) E75.
Interestingly, addition of the DHR3 AF2 peptide to Fe(II)
E75 had no further effect on E75 stability beyond the
effect of CO alone. This lack of an effect beyond that
of CO suggests that the DHR3 AF2 is unable to bind
E75 in the presence of CO.
To summarize, both NO and CO interact with the re-
duced form of E75 (NO shown by UV absorption only),
and CO, while stabilizing the protein, appears to pre-
vent binding of the DHR3 peptide.
Cell
200Figure 4. Histidine Residues in the E75 LBD Are Essential for Heme Binding and LBD Stability
(A) Amino acid alignments of conserved histidine residues of Drosophila E75 and homologs from other insects, shrimp, and the closest
human nuclear receptors. Numbering is based on the Drosophila E75A sequence.
(B) Sample spectra from histidine mutants following single-step nickel purification. Histidine to alanine is shown in black, histidine to phenyla-
lanine is shown in gray. No mutant for H416A was obtained.Effects of Heme and NO on E75
cTranscriptional Activity
E75 acts as a repressor in transient transfection assays h
d(White et al., 1997). Both the DNA binding E75A isoform
and the non-DNA binding E75B isoform can hetero- m
Edimerize with DHR3, blocking its ability to activate tran-
scription (Sullivan and Thummel, 2003; White et al., 1997). a
tTo determine the effects of heme and NO on these
activities, we established a luciferase reporter assay T
ousing Drosophila Kc cells and tested the effects of sup-
plemental heme and NO donor molecules on E75 activ- r
tity. The reporter gene constructed contains consensus
binding sites for E75A and DHR3 (EAR: sites; White et F
Cal., 1997).
Figure 7 shows that, consistent with previous results
(White et al., 1997), DHR3 on its own acts as a tran- D
scriptional activator (w10-fold over basal) and, when
cotransfected with either E75A or E75B, is reduced in W
sactivity by 3- to 4-fold (using equal amounts of trans-
fected DHR3 and E75 vector DNA). Adding supplemen- c
gtal heme further reduces the levels of reporter gene ex-
pression to near background levels (data not shown). t
ABased on our earlier results with E75 expression in bac-
teria and cultured cells, we assume the latter is most h
nlikely due to an increase in E75 stability and accumu-
lation.The ready availability of NO donors with half-lives
ompatible with the time course of incubation (24–48
r) allowed us to examine the effects of NO in situ. Ad-
ition of 200 M DETA-NO (T1/2 w20 hr) to the culture
edia significantly affects the ability of both E75A and
75B to interfere with DHR3-mediated transcriptional
ctivation, returning the levels of DHR3 activity close
o the levels obtained in the absence of E75 isoforms.
his effect was E75 specific, as no effects were seen
n DHR3 on its own (Figure 7B) or on other nuclear
eceptors (data not shown). To summarize, NO appears
o function as an antagonist of E75 repressor activity.
urther testing will be required to determine if and how
O affects E75 transcriptional activity.
iscussion
e have shown, using electronic absorption and mass
pectrometry, that the Drosophila nuclear receptor E75
ontains a single tightly associated heme prosthetic
roup. Thus, nuclear receptor LBDs can now be added
o the limited repertoire of known heme binding motifs.
ll results here are consistent with a conventional
eme-protein interaction mediated by a pair of coordi-
ate bonds. Two highly conserved histidine residuesare good candidates for the interacting residues.
E75 is a Heme-Containing Nuclear Receptor
201Figure 5. Peptide Binding
(A) Summary of changes in transition temperatures upon addition of peptides to E75 Fe(II). Change is relative to E75 Fe(II) without peptide.
The letter C on the left denotes the control reaction: FTZ-F1 binding to the FTZ-derived LXXLL peptide relative to FTZ-F1 alone. The peptide
derived from the putative AF2 helix of HR3 is indicated. Results are shown as the average of duplicate data sets ± standard deviation (SD).
(B) Sample transition curves of FTZ-F1 in the presence (black circles) or absence (gray squares) of FTZ LXXLL peptide.
(C) Sample transition curves of Fe(II) E75 in the presence (black circles) or absence of (gray squares) the DHR3 AF2 peptide.
(D) Effect of E75 oxidation state on Stargazer-monitored interactions in the presence of FTZ (white) or DHR3 AF2 (gray) peptides. Changes
are relative to FTZ-F1 (shown as a control), E75 Fe(III), or E75 Fe(II) in the absence of peptide. Results are shown as the average of duplicate
data sets ± SD.Our results suggest three general ways in which E75-
heme may function. First, the necessity of heme for E75
LBD stability and the changes in expression levels
brought about by supplemental heme suggest that E75
may function as a nuclear monitor of cellular heme
levels. Second, the ability of E75-heme to switch be-
tween oxidized and reduced states and the effects of
these states on CO, NO, and cofactor peptide binding
suggest a possible role as a cellular redox sensor.
Third, the ability of E75-heme to bind NO and CO, and
for these gases to modulate cofactor binding and tran-
scriptional activity, suggests a role in mediating NO
and/or CO intercellular signaling. This is the first exam-
ple of a nuclear receptor with a bipartite ligand bind-
ing system.
Heme as a Nuclear Receptor Ligand
Nuclear receptors were first characterized based on
their ability to bind steroid hormones but are nowknown to bind a fairly diverse set of lipophilic mole-
cules including fatty acids, phospholipids, retinoids,
bile acids, farnesoids, and a range of xenobiotics. Like
most other nuclear receptor ligands, heme is also a li-
pophilic molecule with polarized negative charges. Its
molecular weight and solvent-excluded volume, al-
though larger than most, are within the range of other
known ligands. For example, one of the closest verte-
brate homologs to E75, Peroxisome proliferator activa-
tor receptor γ (PPARγ), has a pocket that can easily ac-
commodate a molecule of this size (Nolte et al., 1998;
Xu et al., 1999). Although heme is not dissimilar to other
ligands in most physical attributes, an iron atom within
a protoporphyrin ring brings an exciting new dimension
to the potential molecular and physiological roles of
nuclear receptor proteins.
E75 as a Heme Sensor
The tight interaction generally formed between heme
molecules and their protein partners, also observed
Cell
202Figure 6. Fe(II) E75 Binds Diatomic Gases
(A) Electronic absorption spectra of Fe(II)
E75 without gas (black), plus CO (dark gray),
and plus NO (light gray).
(B) Effect of CO binding as observed by Star-
gazer. Changes are relative to E75 Fe(II) in
the absence of peptide. Results are shown
as the average of duplicate data sets ± SD.free heme in the cell would determine the levels of E75Although we have not found evidence for such cofac-
Figure 7. Effects of NO on E75 Transcrip-
tional Activity
(A) Schematic representation of the con-
structs used for the full-length nuclear re-
ceptor reporter assay.
(B) Effects of exogenous NO on transcrip-
tional activity. Empty bars represent un-
treated cells and black bars represent cells
treated with NO donor. Labels below each
pair of bars indicate the combination of ex-
pression constructs transfected. “Control”
represents reporter only. Results are shown
as the average of triplicate data sets ± SD.
(C) Proposed model of E75-gas regulation of
HR3 transcriptional activation.with E75, and our inability to detect apo-E75 suggest t
cthat E75 and heme are unlikely to associate and disso-
ciate readily. For this to occur, dedicated cofactors I
owould be required to shuttle the heme in and out of the
LBD and to stabilize the LBD in the absence of heme. sors, it is possible that endogenous E75 is expressed in
ertain tissues or stages in which such cofactors exist.
f, on the other hand, these cofactors are not present,
r do not exist, heme would be required as a dedicated
tructural component. In the latter case, the levels of
E75 is a Heme-Containing Nuclear Receptor
203that can accumulate. Either way, heme availability
would determine the levels of active E75 in the cell. If
E75 target genes include regulators of heme metabo-
lism, these properties would make E75 an ideal regula-
tor of heme homeostasis. Processes potentially af-
fected by this are discussed below.
Heme is required by proteins that control an enor-
mous range of cellular and biological processes. Exam-
ples of these processes (and proteins) include energy
transfer (mitochondrial cytochromes), lipid and drug
metabolism (cytochrome P450s), heme metabolism
(heme oxygenase [HO]), oxygen radical detection and
removal (superoxide dismutases, catalase, NADPH hy-
droxylase), gas transport (hemoglobin, myoglobin), iron
transport (HO-FE-ATP pump), neuronal differentiation,
and behavior (guanylate cyclase, nitric-oxide synthase
[NOS]) and circadian rhythm (HO, NPAS2) (see Pardee
et al., 2004; Ryter and Otterbein, 2004; Wagener et al.,
2003 and references therein). Interestingly, NOS and
HO, the enzymes that produce NO and CO in the cell,
are also heme-containing proteins (discussed further
below).
Of the physiological processes listed above, particu-
larly intriguing and relevant ones are lipid and xenobio-
tic metabolism. In vertebrates, most of the enzymes
that regulate these reactions are cytochrome P450s,
which typically use heme to transfer oxygen or hydroxyl
groups to or from their substrates (Poulos, 1988). Ho-
meostasis between lipid absorption/production and
secretion/breakdown is controlled by nuclear recep-
tors, largely through transcriptional regulation of cyto-
chrome P450 (cyp) genes (reviewed in Chawla et al.,
2001). In turn, the substrates or products of the P450-
regulated reactions are often ligands for the nuclear re-
ceptors that regulate expression of the respective P450
genes. This triangular relationship between transcrip-
tional regulators, enzymes, and reaction products pro-
vides the necessary feedback for homeostasis. Given
that a close link between heme and lipid metabolism is
also well documented (Bauer et al., 2004; Chawla et al.,
2001; Lorenz and Parks, 1991; Pardee et al., 2004), the
ability of a nuclear receptor to monitor levels of heme
could provide a general mechanism for coordinating
these processes.
E75 as a Redox Sensor
The iron center of E75 can reversibly switch between
Fe(III) and Fe(II) oxidation states. Furthermore, the in-
teraction with an HR3-derived peptide is selective for
the Fe(II) oxidation state of E75-heme. This set of char-
acteristics sets up the intriguing possibility of E75 act-
ing as a direct redox sensor. An interesting example of
this behavior is the reported heme-based redox sensor
activity of Ec-DOS (Kurokawa et al., 2004; Sasakura et
al., 2002), a phosphodiesterase in E. coli. Enzymatic ac-
tivity is modulated by an allosteric change in the heme-
containing PAS domain. The heterodimerization and
transcriptional activities of the NPAS2 and Bmal1 tran-
scription factors, which regulate circadian rhythm, have
also been shown to depend on redox potential in vitro
(Rutter et al., 2001). NPAS2 has two heme-containing
PAS domains (Dioum et al., 2002), which could provide
the mechanism for redox detection. Ec-DOS and
NPAS2 also function as gas sensors (see below).E75 as a Substrate for Gas Ligands
In many heme bound proteins, the heme molecule
serves as a cofactor or prosthetic group for the binding
of diatomic gases. Our results show that this is also the
case for E75-heme, and that NO and CO may serve as
E75 ligand(s). Although small, these diatomic gases
have been shown to bring about significant changes in
protein structure. In heme-containing proteins such as
hemoglobin, myoglobin, guanylate cyclase, CooA, and
FixL, for example, the binding of O2, CO, or NO causes
allosteric rearrangements that modulate protein multi-
merization, enzymatic activity, and/or the ability to in-
teract with cofactors or target molecules (reviewed in
Gilles-Gonzalez and Gonzalez, 2005).
In the case of E75, our peptide binding studies sug-
gest that CO interferes with the ability of E75 to interact
with the DHR3 AF2 motif. Although unable to confirm
this by direct binding assays, our results with NO on
E75 transcriptional activity suggest that NO may act
similarly. This may be analogous to the case of soluble
guanylate cyclase, where NO and CO binding both lead
to functional activation, but to varying degrees (for re-
view, see Jain and Chan, 2003). As with other nuclear
receptors, proper placement of the DHR3 AF2 helix
within its ligand binding domain is most likely required
for DHR3 to bind transcriptional coactivators. If E75
were to sequester the DHR3 AF2 helix, then DHR3 ac-
tivity would be compromised. By reversing the AF2-E75
interaction, NO and/or CO could then restore normal
DHR3-coactivator interactions (modeled in Figure 7C).
General Roles of NO and CO
NO and CO are coming to be implicated in a rapidly
growing list of processes in vertebrates (Ignarro, 2000;
Ryter and Otterbein, 2004), plants (Neill et al., 2003),
and insects (Bicker, 2001). Their ability to diffuse readily
between and within cells, and their short half-lives,
make them ideal intercellular signaling molecules. In
many cases, they act together or in opposition. Exam-
ples of processes regulated by NO and CO include
blood pressure, cell division, cell death, inflammation,
metabolism, hypoxia, diurnal cycles, behavior, and
memory (Ignarro, 2000; Ryter and Otterbein, 2004; Sny-
der and Ferris, 2000). The primary source of NO in tis-
sues is the enzyme NOS and for CO, HO. In flies, muta-
tion of the dnos gene results in embryonic lethality
(Regulski et al., 2004). Flies also contain a single HO
gene (Zhang et al., 2004), but genetic and functional
analyses of dHO are yet to be carried out.
The fact that CO production is dependent upon heme
as a substrate, that NOS and HO both have heme cen-
ters, and that they have related physiological functions
poses an interesting set of coincidences. This and the
convergence of heme with lipid synthesis and related
processes, NO and CO gas binding and now E75 func-
tion (reviewed in Pardee et al., 2004), suggests that E75
may provide a unifying role in the regulation of these
processes.
Possible Roles for E75-Heme in Insects
Numerous studies have placed E75 genetically, tran-
scriptionally, and functionally in the ecdysone response
pathway, both upstream and downstream of the ecdy-
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204sone receptor (Bialecki et al., 2002; Segraves and Hog- g
ness, 1990; Sullivan and Thummel, 2003). Thus, E75 ap- l
pears to play roles in both ecdysone production and o
response. Ecdysone-regulated processes during insect t
development include cuticle formation, molting, pro- s
grammed cell death, neurogenesis, imaginal disk de- s
velopment, and oogenesis (Brennan et al., 1998; Busz- n
czak et al., 1999; Ward et al., 2003). The binding of E75 p
to heme suggests possible connections between these 1
processes and heme metabolism or function. This D
could occur at a variety of different levels. Some intrigu- t
ing possibilities include the regulation of hormone-syn- e
thesis pathways, oogenesis arrest, metabolism, and the w
control of circadian rhythm. These possible roles are 1
discussed briefly below. t
As discussed earlier, an intimate functional triangle i
exists between nuclear receptor function, cytochrome c
P450 expression, and cytochrome P450 substrates.
This relationship, taken together with the apparent p
need for E75 in ecdysone production and response, s
suggests the possibility that E75 could control ecdyst- e
eroid metabolism by regulating the transcription of key t
cyp genes, or more globally by sensing the levels of a
available heme. The possible ability of E75 to regulate a
hormone synthesis, and its known role in controlling the d
progression of molts, metamorphosis, and oogenesis, m
also brings up other intriguing possible functions. One
example might be the ability to monitor energy re- E
sources such as lipids and to coordinate these levels
Ewith developmental progression. More specifically, the
Fclose link between heme, NO, and lipid metabolism
Gcould be used to block or postpone molting, pupar-
t
iation, or oogenesis when energy resources are low, p
and vice versa. i
Interestingly, in mosquitoes, oogenesis is halted prior f
oto chorion deposition until the insect obtains a blood
Emeal. Although the blood-meal components that re-
Nlease the oogenesis arrest have yet to be identified, one
r
of the major components of the blood meal is heme c
removed from the metabolized hemoglobin. Taken to- d
gether with the observations that one of the responses m
of the blood meal is a pulse of ecdysone synthesis and m
(action and that in Drosophila, E75 functions in both a
feed forward and downstream role in the ecdysone sig-
bnaling pathway, E75 may play a key role in this re-
a
sponse by responding to the ingested heme and induc- v
ing ecdysone synthesis. a
A number of possible links also exist between E75 E
pfunction and a role in regulating circadian rhythms.
wFirst, NO, CO, and heme appear to be important regula-
btors of circadian oscillators. In vertebrates, “light” and
“dark” inputs are thought to be converted to signals of
PNO and CO, which in turn modulate the phase and
P
period of the circadian cycle (Artinian et al., 2001; Ding m
et al., 1994). Heme biosynthesis is also reciprocally reg- o
ulated by the circadian clock (Kaasik and Lee, 2004). d
Second, the closest homolog to E75 in vertebrates, 4
eRev-Erbα, is a well-established regulator of circadian
wrhythm in mammals, also acting as a transcriptional re-
upressor and competing with the nuclear receptor
i
RORα, which is a transcriptional activator of the circa- f
dian regulator Bmal1 (Akashi and Takumi, 2005; Naka- p
jima et al., 2004; Preitner et al., 2002; Sato et al., 2004). 2
wThe interaction between Rev-Erbα and RORα is analo-ous to that of E75 and HR3, their closest insect homo-
ogs. Third, each larval instar molt, as well as the onset
f metamorphosis and adult eclosure, are coupled to
he circadian clock. Molts between first and third in-
tars occur every 24 hr, and metamorphosis and eclo-
ure generally begin on the mornings of the fifth and
inth days. These events are regulated by rhythmic
ulses of juvenile hormone and ecdysone (Thummel,
995), which are under E75 control (Bialecki et al., 2002;
ubrovskaya et al., 2004; Thummel, 1995). In insects
hat take longer to develop, such as Rodnius (21 days),
cdysone levels have been shown to oscillate daily,
ith levels highest at night (Vafopoulou and Steel,
996a; Vafopoulou and Steel, 1996b). E75 may time
hese oscillating events indirectly by monitoring feed-
ng activity (lipid intake) or through a more direct role in
ircadian rhythm.
An interesting implication of this study is that the or-
han receptor, Rev-Erbα, may also bind heme and re-
pond to diatomic gases. If it does not, compensating
volutionary steps may have been adopted to maintain
he circuitry of E75-heme-regulated processes. It is
lso possible that other nuclear receptors may have
dopted or conserved the capacity to bind heme and
iatomic gases and to regulate corresponding develop-
ental and physiological functions.
xperimental Procedures
xpression Constructs
or bacterial expression, the E75 LBD, consisting of amino acids
341–S602, was subcloned into the vector pET15B (Invitrogen) be-
ween the NdeI and BamHI restriction sites. For baculovirus ex-
ression, the vector pFASTBAC DUAL (Invitrogen) was modified to
nclude a His6 tag and a thrombin cleavage site. These were taken
rom pET15b (Novagen) and inserted into the BamHI and NotI sites
f the modified baculovirus vector. Coding regions for full-length
75A and E75 LBD (residues A345–G604) were inserted into the
otI and XbaI sites of pFASTBAC DUAL (Invitrogen), to generate
ecombinant baculoviruses. For expression in flies and Drosophila
ells grown in culture, E75 LBD (A345–G604) was subcloned into a
erivative of pCaSpeR-hs-act (C. Thummel) named pTetraCasper,
ade by adding a 4-tag cassette, consisting of protein A, Cal-
odulin, 3×FLAG, and His6 upstream of the multiple cloning site
plasmid construction is described in detail in Yang et al., 2005).
For cotransfection studies, the reporter pEar1-Luc was obtained
y inserting three recognition sites for E75A and DHR3 (Horner et
l., 1995) upstream of the basal promoter of the luciferase reporter
ector pGL3 (Promega). Expression vectors pMT-E75A, pMT-E75B,
nd pMT-HR3 were constructed by inserting full-length E75A,
75B, and HR3 sequences into the NotI and XbaI sites of
MTv5HisA (Invitrogen). cDNA templates for the PCR reactions
ere kindly provided by C. Thummel. All constructs were verified
y sequencing.
rotein Purification
rotein expressed in E. coli was purified using Ni-NTA affinity chro-
atography as described elsewhere (Zhang et al., 2001). Following
vernight cleavage by thrombin proteinase at 4°C, the sample was
iluted to 20 mM salt using buffer Q0 (10 mM tris•HCl [pH 8.0] at
°C, 5% v/v 1,2-propanediol, 5 mM DTT) and loaded onto an anion
xchange column (Q Fast-Flow [Amersham Biosciences]). Protein
as eluted with a linear salt gradient (Q0 plus 30 mM–2M NaCl)
sing an AKTA FPLC (Amersham Biosciences). Fractions contain-
ng pure E75 were identified by 280/425 nm absorbance and veri-
ied by SDS-PAGE. E75 constructs purified from Spodoptera frugi-
erda (SF9) were prepared as described elsewhere (Orlicky et al.,
001). When used, aminolevulinic acid and hemin (50 mg/l, Sigma)
ere added 2 days postinfection. Schneider 2 (S2) cells carrying a
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205multiply tagged E75 LBD construct (pCaSpeR-Tetra-E75LBD) and
full-length E75 proteins were grown as suspension cultures and
purified using tandem anti-FLAG and Ni-NTA affinity columns.
Transgenic fly lines expressing pCaSpeR Tetra E75 LBD were
grown to the pupal stage, induced by a 20 min heat shock, har-
vested, homogenized, clarified, and purified as above (described
in detail in Yang et al., 2005). Reduction of the heme center of E75-
heme was achieved by adding 1 mM sodium dithionite (Sigma).
His Mutants
The bacterial E75 LBD expression vector, described above, was
used as the template to mutagenize the four conserved His resi-
dues using the quickchange mutagenesis protocol (Invitrogen). All
mutants were verified by sequencing, except for H416A, which was
not obtained. Proteins were expressed and purified as above with
a single affinity column and analyzed by electronic absorption.
Mass Spectrometry
Mass spectrometry analyses were carried out using a quadrupole
time-of-flight mass spectrometer (Q-TOF, Micromass) equipped
with a nano electrospray (ES) source. In preparation for MS, an
additional gel filtration step, using a Superdex 16/60 column (Amer-
sham), was performed. Samples (5 mg/ml) were then desalted in
four dilution/concentration steps using centrifugal concentration
into 20 mM ammonium acetate (pH 6.2) until a concentration of 1
mg/ml was reached. Samples were loaded on a gold-coated capil-
lary (Protona) with the tip manually opened to produce an orifice of
approximately 10 m. Positive ES was performed at a capillary
voltage of 1.8 to 2 kV and cone voltage of 50V. CID experiments
were carried out with a collision energy of 80V using argon as the
collision gas. Average molecular masses were calculated using
Mass Lynx 4.0 (Micromass).
Guanidine-HCl Denaturation
Nickel beads (1 ml) bound with E75 LBD were washed with 1.5 ml
wash buffer (500 mM NaCl and 3% 1,2-propanediol with GdnHCl
at concentrations of 0, 0.1, 0.25, 0.3, 0.4, 0.5, 0.6, 0.75, 1, 2, 3, 4,
or 5 M. The absorbance of eluted fractions was monitored at two
wavelengths; 425 nm is λmax of native E75-heme (see Figure 1),
395 nm represents λmax of free heme as well as E75-heme under
denaturing conditions (data not shown). Protein remaining on the
column after the last treatment was eluted using buffer F (0.2 M
acetic acid, 6 M GdnHCl).
Gas Binding In Vitro
Storage buffer (10 mM Tris [pH 8.0] at 4°C, 500 mM NaCl) was
degassed and then saturated with CO (Praxair). Based on the mole
fraction solubility of CO in water (Gevantman, 2004), the concentra-
tion of this CO stock solution was estimated at 1 mM. CO-saturated
solution was added to 1 mg/ml reduced protein samples at 1:10
volume ratio, providing an approximately 3-fold molar excess of
CO in solution. Storage buffer supplemented with 200 mM Tris•Cl
was degassed and saturated with NO gas (Aldrich), then adjusted
to pH 8.0. The estimated concentration of NO saturated solution
was 1.9 mM and was added to protein samples at a 1:20 volume
ratio. Argon and O2 gases (Praxair) were added to samples directly
by bubbling for 10 min.
Peptide Assays
Forty-six unique fluorescein-labeled peptides based on LXXLL-
containing and other suspected nuclear receptor-interacting motifs
from fly and human proteins were designed and ordered (Sigma
Genosys). Forty of the peptides were successfully synthesized.
Crude peptides were screened for binding to E75 using Stargazer
(Affinium Parmaceuticals). Briefly, protein samples were heated
from 27°C to 80°C at the rate of 1°C per minute in clear bottom 384
well plates (Nunc), and protein aggregation was monitored. Images
of scattered light were captured every 30 s and the light intensities
were translated to arbitrary numbers. Intensities were plotted
against temperature for each sample well, and transition curves
were fitted using the Boltzmann equation. The midpoint of each
transition was identified and is referred to as the transition temper-
ature. Each well contained 50 l of 200 M peptide, 0.4 mg/ml E75LBD (13 M), 200 mM Tris (pH 8.0) at 4°C, 150 mM NaCl, and 2.5
mM CaCl covered by 50 l of mineral oil. Each peptide was tested
with and without reducing agent and in duplicate. Samples were
also tested with CO present at a 5 molar excess (60 M).
Transcription Assays
Kc cells (15 × 106) were transfected in duplicate with 8 g each of
one of the following expression plasmids: pMT-E75A, pMT-E75B,
or pMT-HR3, together with 8 g of the reporter pEarl-Luc and 4
g of the transfection control plasmid pPAC-β-gal using Cellfectin
(Invitrogen). Cells were grown overnight at 27°C, washed, and in-
duced 8 hr later with 500 M CuSO4. After 48 hr, cells were collected,
lysed, and assayed for luciferase activity (Promega). β-galactosidase
(β-gal) activity was measured by adding equal volumes of lysate
and buffer containing o-nitrophenyl-β-D-galactopyranoside (OPNG).
Hydrolysis of OPNG (colorless) to o-nitrophenyl (yellow) by β-gal
was measured at 420 nm. Luciferase measurements were normal-
ized to β-gal activities and presented as a ratio of the values ob-
tained with untreated cells. Transfections were conducted in paral-
lel in four separate experiments and the numbers averaged. Where
used, hemin (Sigma) dissolved in DMSO, was added to the cells to
a final concentration of 1.5 mM 16 hr after induction with CuSO4,
and 2,2#-(Hydroxynitrosohydrazino) bis-ethanamine (DETA-NO) (Sig-
ma) was added 24 hr following CuSO4 induction.
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